Clinical trial

Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating…

NCT00002819 · Gynecologic Oncology Group, Other · Terminated

Key facts

NCT number NCT00002819
Title Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer
Official title A RANDOMIZED, CONTROLLED TRIAL OF SALVAGE THERAPY WITH PACLITAXEL AND CARBOPLATIN VERSU SALVAGE THERAPY WITH STEM CELL SUPPORTED HIGH-DOSE CARBOPLATIN, MITOXANTRONE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH PERSISTENT LOW VOLUME OVARIAN CANCER AND RESPONSE TO PRIMARY THERAPY
Lead sponsor Gynecologic Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group SWOG Cancer Research Network Cancer and Leukemia Group B
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Ovarian Cancer
Intervention type Drug, Procedure
Interventions carboplatin, cyclophosphamide, mitoxantrone hydrochloride, paclitaxel, autologous bone marrow transplantation, peripheral blood stem cell transplantation
Start date Nov 1, 1996
Primary completion Feb 1, 2000
First posted May 26, 2004
Last update posted Apr 11, 2013
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies